News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
791,751 Results
Type
Article (50379)
Company Profile (710)
Press Release (740643)
Multimedia
Podcasts (137)
Webinars (27)
Section
Business (223002)
Career Advice (2729)
Deals (38781)
Drug Delivery (146)
Drug Development (87010)
Employer Resources (187)
FDA (17717)
Job Trends (16582)
News (377262)
Policy (36120)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2750)
Academic (1)
Accelerated approval (44)
Adcomms (32)
Allergies (173)
Alliances (54125)
ALS (206)
Alzheimer's disease (1849)
Antibody-drug conjugate (ADC) (402)
Approvals (17984)
Artificial intelligence (648)
Autoimmune disease (243)
Automation (52)
Bankruptcy (402)
Best Places to Work (12319)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (440)
Bladder cancer (184)
Brain cancer (71)
Breast cancer (713)
Cancer (5567)
Cardiovascular disease (488)
Career advice (2310)
Career pathing (45)
CAR-T (320)
CDC (63)
Celiac Disease (2)
Cell therapy (865)
Cervical cancer (42)
Clinical research (74559)
Collaboration (2048)
Company closure (6)
Compensation (1311)
Complete response letters (89)
COVID-19 (2934)
CRISPR (108)
C-suite (1050)
Cystic fibrosis (155)
Data (7218)
Decentralized trials (3)
Denatured (32)
Depression (173)
Dermatology (59)
Diabetes (575)
Diagnostics (7297)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (315)
Drug pricing (228)
Drug shortages (34)
Duchenne muscular dystrophy (280)
Earnings (97671)
Editorial (67)
Employer branding (24)
Employer resources (163)
Events (130604)
Executive appointments (1105)
FDA (21245)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1706)
Gene editing (232)
Generative AI (57)
Gene therapy (720)
GLP-1 (1172)
Government (5031)
Grass and pollen (8)
Guidances (399)
Healthcare (20134)
HIV (77)
Huntington's disease (57)
IgA nephropathy (95)
Immunology and inflammation (318)
Immuno-oncology (90)
Indications (158)
Infectious disease (3266)
Inflammatory bowel disease (218)
Inflation Reduction Act (15)
Influenza (133)
Intellectual property (283)
Interviews (500)
IPO (17805)
IRA (57)
Job creations (4648)
Job search strategy (1899)
JPM (68)
Kidney cancer (19)
Labor market (96)
Layoffs (655)
Leadership (42)
Legal (9076)
Liver cancer (104)
Longevity (29)
Lung cancer (743)
Lymphoma (415)
Machine learning (54)
Management (64)
Manufacturing (982)
MASH (191)
Medical device (14905)
Medtech (14987)
Mergers & acquisitions (22149)
Metabolic disorders (1546)
mRNA (204)
Multiple sclerosis (179)
NASH (22)
Neurodegenerative disease (424)
Neuropsychiatric disorders (112)
Neuroscience (3345)
Neurotech (1)
NextGen: Class of 2026 (7232)
Non-profit (4692)
Now hiring (74)
Obesity (752)
Opinion (339)
Ovarian cancer (188)
Pain (243)
Pancreatic cancer (267)
Parkinson's disease (357)
Partnered (36)
Patents (572)
Patient recruitment (620)
Peanut (64)
People (64692)
Pharmaceutical (127)
Pharmacy benefit managers (36)
Phase 1 (23260)
Phase 2 (32775)
Phase 3 (24494)
Pipeline (7297)
Policy (348)
Postmarket research (2732)
Preclinical (9886)
Press Release (71)
Prostate cancer (288)
Psychedelics (61)
Radiopharmaceuticals (328)
Rare diseases (1089)
Real estate (6798)
Recruiting (76)
Regulatory (27206)
Reports (58)
Research institute (2548)
Resumes & cover letters (442)
Rett syndrome (33)
RNA editing (19)
RSV (94)
Schizophrenia (177)
Series A (289)
Series B (213)
Service/supplier (27)
Sickle cell disease (114)
Special edition (28)
Spinal muscular atrophy (177)
Sponsored (47)
Startups (4174)
State (2)
Stomach cancer (20)
Supply chain (124)
Tariffs (102)
The Weekly (102)
Vaccines (1179)
Venture capital (109)
Weight loss (506)
Women's health (111)
Worklife (23)
Date
Last 7 days (661)
Last 30 days (2564)
Last 365 days (31654)
2026 (8451)
2025 (31978)
2024 (37503)
2023 (42290)
2022 (53624)
2021 (58271)
2020 (56799)
2019 (49702)
2018 (37683)
2017 (35338)
2016 (35297)
2015 (41317)
2014 (35316)
2013 (30230)
2012 (32242)
2011 (32694)
2010 (30605)
Location
Africa (889)
Alabama (99)
Alaska (7)
Arizona (352)
Arkansas (15)
Asia (45851)
Australia (7577)
California (12704)
Canada (3570)
China (1322)
Colorado (543)
Connecticut (545)
Delaware (379)
Europe (102165)
Florida (1892)
Georgia (406)
Hawaii (4)
Idaho (66)
Illinois (1011)
India (88)
Indiana (592)
Iowa (24)
Japan (503)
Kansas (137)
Kentucky (48)
Louisiana (43)
Maine (85)
Maryland (1545)
Massachusetts (9298)
Michigan (374)
Minnesota (716)
Mississippi (6)
Missouri (151)
Montana (36)
Nebraska (30)
Nevada (142)
New Hampshire (89)
New Jersey (3424)
New Mexico (32)
New York (3359)
North Carolina (1720)
North Dakota (10)
Northern California (6216)
Ohio (391)
Oklahoma (24)
Oregon (52)
Pennsylvania (2546)
Puerto Rico (27)
Rhode Island (53)
South America (1326)
South Carolina (78)
South Dakota (1)
Southern California (4958)
Tennessee (201)
Texas (2019)
United States (45514)
Utah (384)
Vermont (1)
Virginia (318)
Washington D.C. (88)
Washington State (1042)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
791,751 Results for "austin chemical company inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
April 2, 2026
·
4 min read
Press Releases
Fujitsu and The University of Osaka develop new technologies for chemical material energy calculations on early-FTQC quantum computers
March 25, 2026
·
2 min read
Press Releases
Omnicell Opens New Innovation Lab in Austin, Texas
May 15, 2025
·
6 min read
Press Releases
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
May 20, 2025
·
11 min read
Business
AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors
AbbVie (NYSE: ABBV) today announced that the independent directors of the board have selected Roxanne S. Austin as lead independent director, effective July 1, 2024.
June 20, 2024
·
4 min read
Lone Star Bio
Mann Eye Institute Unveils State-of-the-Art Office-Based Surgery Center in Austin
Mann Eye Institute announces the grand opening of its office-based surgery center, Mann Austin Surgery Center, at 4314 W. Braker Lane, Suite #215, Austin, TX 78759.
June 26, 2024
·
2 min read
Business
Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024
Monogram Technologies Inc., an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, will host an investor and analyst day on Thursday, June 20th, 2024, from 9:00 a.m. CDT to 1:00 p.m. CDT at its cadaver lab and headquarters in Austin, Texas.
June 3, 2024
·
5 min read
Press Releases
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025
December 18, 2025
·
5 min read
Press Releases
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc.
March 19, 2026
·
6 min read
Press Releases
Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
March 18, 2026
·
10 min read
Previous
2 of 79,176
Next
